Chief Development Officer
Mycovia Pharmaceuticals, Inc
Durham, NC, United States
As Chief Development Officer at Mycovia Pharmaceuticals, Dr Brand provides strategic direction and technical leadership to the clinical development and medical affairs teams. He is responsible for the overall management and performance of the company’s antifungal clinical development programs in women’s health and other areas. Dr. Brand most recently served as Vice President, Clinical Development at Viamet Pharmaceuticals where he led cross-functional project teams, resulting in the successful completion of clinical studies in vaginal candidiasis and onychomycosis. He previously served as President of Agile Sciences and Director at Argos Therapeutics. Dr. Brand has held senior positions at BioStratum, Inc., and Cato Research Ltd.
Dr. Brand is a graduate member of the Institute of Biology (GiBiol) and holds a PhD from the School of Medicine, University of Manchester, England. He completed his post-doctoral fellowship at Cold Spring Harbor Laboratory, NY.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Saturday, October 22, 2022
8:00 AM – 9:00 AM US ET
Saturday, October 22, 2022
8:50 AM – 9:00 AM US ET